Geffner Michael
Immunovant, Inc. · Chief Medical Officer
Geffner Michael is listed in filings as Chief Medical Officer at Immunovant, Inc.. This profile follows SEC Form 4 activity through Oct 24, 2025, including sale activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from Jul 26, 2024 to Oct 24, 2025. Reported amounts are shown as $95.9K to $62.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $96k3.5k shares | SellJul 24, 2024 | $27.76 | $38.96 | |
| $94k3.2k shares | SellOct 23, 2024 | $29.53 | $38.96 | |
| $63k2.7k shares | SellJan 22, 2025 | $23.59 | $38.96 | |
| $35k2.3k shares | SellApr 23, 2025 | $14.79 | $38.96 | |
| $20k1.2k shares | SellJul 9, 2025 | $17.24 | $38.96 | |
| $43k2.4k shares | SellJul 23, 2025 | $18.15 | $38.96 | |
| $21k1.3k shares | SellOct 8, 2025 | $16.30 | $38.96 |